Cutaneous T Cell Lymphoma Clinical Trials

125 clinical trials for Cutaneous T Cell Lymphoma across international registries, including 24 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment — RECRUITING
• Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma — RECRUITING · PHASE1
• A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma — RECRUITING · NA
• A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL) — RECRUITING · PHASE1
• A Phase 2 Trial to Assess Safety and Efficacy of Tofacitinib 2% Cream in the Treatment of Cutaneous T-cell Lymphoma (CTCL), Stages IA, IB, and IIA — RECRUITING · PHASE2
• Combating Cancer-Related Fatigue: A Personalized Supportive Care Program — RECRUITING · NA
• Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas — RECRUITING · PHASE2
• An Open-Label, Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PTX-100 Monotherapy in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma. — RECRUITING · PHASE2
• Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash — RECRUITING
• Characterization of the Microbiome in Cutaneous T Cell Lymphoma — RECRUITING
• Photopheresis in Early-stage Mycosis Fungoides — RECRUITING · PHASE2
• Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma — RECRUITING · PHASE2
• Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL) — RECRUITING · PHASE1
• A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides — RECRUITING · PHASE1
• Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research — RECRUITING
• Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma — RECRUITING
• JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas — RECRUITING · PHASE2
• Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma — RECRUITING · PHASE1
• Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL — RECRUITING
• A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies — RECRUITING · PHASE1
• MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy — RECRUITING · NA
• Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab — RECRUITING
• A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma — RECRUITING
• SOLAR: A PHASE 2, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP, ACTIVE COMPARATOR, MULTI-CENTER STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF COBOMARSEN (MRG-106) IN SUBJECTS WITH CUTANEOUS T-CELL LYMPHOMA (CTCL), MYCOSIS FUNGOIDES (MF) SUBTYPE — RECRUITING · PHASE2
• Phase II Trial of Pembrolizumab and Radiotherapy in Cutaneous T cell lymphoma — OTHER · PHASE2
• A RANDOMISED, OPEN-LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF BEXAROTENE (TARGRETIN) CAPSULES COMBINED WITH PUVA, COMPARED TO PUVA TREATMENT ALONE IN PATIENTS WITH MYCOSIS FUNGOIDES. — COMPLETED · PHASE3
• Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies — COMPLETED · PHASE1
• A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides — NOT_YET_RECRUITING · PHASE1
• Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL — TERMINATED · PHASE3
• Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell Lymphoma — NOT_YET_RECRUITING · PHASE2
• Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides — SUSPENDED · PHASE1
• Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL — ACTIVE_NOT_RECRUITING · PHASE1
• Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma — COMPLETED
• Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution — NOT_YET_RECRUITING · PHASE1
• Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma — NOT_YET_RECRUITING · PHASE1
• Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light — COMPLETED · PHASE2
• A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL) — NOT_YET_RECRUITING · PHASE1
• Romidepsin Maintenance After Allogeneic Stem Cell Transplantation — COMPLETED · PHASE1
• A Study to Evaluate the Efficacy and Safety of KW-0761 in Chinese Subjects With Mycosis Fungoides or Sézary Syndrome Previously Treated With Systemic Therapy — ACTIVE_NOT_RECRUITING · PHASE4
• Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance — NOT_YET_RECRUITING · PHASE3
• A Clinical Trial in Adults With Non-Hodgkin Lymphoma (NHL), With a Particular Emphasis on Cutaneous T Cell Lymphoma (CTCL), Testing the Safety and Activity of a Novel Drug to Inhibit a Protein Called Tumor Necrosis Factor Receptor 2 That Drives Both Lymphoma Growth and Escape of the Immune System — NOT_YET_RECRUITING · PHASE1
• Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. — WITHDRAWN · NA
• A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma — COMPLETED · PHASE1
• Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors — COMPLETED · PHASE1
• A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies — ACTIVE_NOT_RECRUITING · PHASE1
• A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) — ACTIVE_NOT_RECRUITING · PHASE2
• Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms — COMPLETED · PHASE2
• Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study — NOT_YET_RECRUITING
• Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment — COMPLETED

Refine this search